Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors

• 主要な著者: Selin Genc (著者), Bahri Evren (著者), Onur Selcuk Yigit (著者), Ibrahim Sahin (著者), Ramazan Dayanan (著者), Aleksandra Klisic (著者), Ayse Erturk (著者), Filiz Mercantepe (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2024-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

<b>Background/Objectives</b>: The antidiabetic effect of SGLT2 inhibitors (SGLT2-is) is based on their ability to increase glucose excretion through urine by inhibiting the kidney-resident SGLT2 protein. Euglycemic diabetic ketoacidosis (EuDKA) is an uncommon but potentially life-threate...